Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
No specific high-affinity BPC-157 receptor has been identified in the published peer-reviewed literature, and current mechanism proposals are drawn from observed effects in preclinical models rather than direct receptor pharmacology
These materials must be handled only by qualified professionals in controlled laboratory settings
Want to learn more about Biote BPC-157 + KPV
The molecule was advanced into clinical development by the Croatian pharmaceutical company Pliva under the designations PL-10, PLD-116, and PL 14736 for inflammatory bowel disease research
Note: BPC-157 is an investigational compound and has not been established as safe or effective for any therapeutic use
Its important to disclose all medications you are taking to avoid dangerous interactions
US$ 23.80
US$ 25.85
US$ 28.19
US$ 29.51
US$ 27.41
US$ 27.10
US$ 26.43
US$ 26.64
